Literature DB >> 26647913

Betulinic Acid Kills Colon Cancer Stem Cells.

Lisette Potze, Simone di Franco, Jan H Kessler, Giorgio Stassi, Jan Paul Medema1.   

Abstract

Cancer stem cells (CSCs) are considered to be the origin of cancer and it is suggested that they are resistant to chemotherapy. Current therapies fail to eradicate CSCs and therefore selecting a resistant cell subset that is able to facilitate tumor recurrences. Betulinic acid (BetA) is a broad acting natural compound, shown to induce cell death via the inhibition of the stearoyl-CoA- desaturase (SCD- 1). This enzyme converts saturated fatty acids into unsaturated fatty acids and is over-expressed in tumor cells. Here we show that BetA induces rapid cell death in all colon CSCs tested and is able to affect the CSCs directly as shown, via the loss of clonogenic capacity. Similar results were observed with inhibition of SCD-1, suggesting that SCD-1 activity is indeed a vulnerable link in colon CSCs and can be considered an ideal target for therapy in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26647913     DOI: 10.2174/1574888x11666151203223512

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  8 in total

Review 1.  Molecular relation between biological stress and carcinogenesis.

Authors:  Katarzyna Rakoczy; Wojciech Szlasa; Natalia Sauer; Jolanta Saczko; Julita Kulbacka
Journal:  Mol Biol Rep       Date:  2022-05-24       Impact factor: 2.742

2.  Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans.

Authors:  Khadijah A Mitchell; Adriana Zingone; Leila Toulabi; Jacob Boeckelman; Bríd M Ryan
Journal:  Clin Cancer Res       Date:  2017-12-01       Impact factor: 12.531

3.  Enzymatic synthesis and in vitro evaluation of folate-functionalized liposomes.

Authors:  Bohong Guo; Danqiao Xu; Xiaohong Liu; Jun Yi
Journal:  Drug Des Devel Ther       Date:  2017-06-20       Impact factor: 4.162

Review 4.  Ovarian Cancer-Why Lipids Matter.

Authors:  Guangyuan Zhao; Horacio Cardenas; Daniela Matei
Journal:  Cancers (Basel)       Date:  2019-11-26       Impact factor: 6.639

Review 5.  Reprogramming of fatty acid metabolism in cancer.

Authors:  Nikos Koundouros; George Poulogiannis
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

Review 6.  Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment.

Authors:  Lisha Bao; Tong Xu; Xixuan Lu; Ping Huang; Zongfu Pan; Minghua Ge
Journal:  Front Oncol       Date:  2021-12-02       Impact factor: 6.244

Review 7.  Emerging role of lipid metabolism alterations in Cancer stem cells.

Authors:  Mei Yi; Junjun Li; Shengnan Chen; Jing Cai; Yuanyuan Ban; Qian Peng; Ying Zhou; Zhaoyang Zeng; Shuping Peng; Xiaoling Li; Wei Xiong; Guiyuan Li; Bo Xiang
Journal:  J Exp Clin Cancer Res       Date:  2018-06-15

Review 8.  Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment.

Authors:  Lara P Fernández; Marta Gómez de Cedrón; Ana Ramírez de Molina
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.